Literature DB >> 22647847

Artificial mirtron-mediated gene knockdown: functional DMPK silencing in mammalian cells.

Yiqi Seow1, Christopher R Sibley, Matthew J A Wood.   

Abstract

Mirtrons are introns that form pre-miRNA hairpins after splicing to produce RNA interference (RNAi) effectors distinct from Drosha-dependent intronic miRNAs. Here we present a design algorithm for artificial mirtrons and demonstrate, for the first time, efficient gene knockdown of myotonic dystrophy protein kinase (DMPK) target sequences in Renilla luciferase 3' UTR and subsequently pathogenic DMPK mRNA, causative of Type I myotonic dystrophy, using artificial mirtrons cloned as eGFP introns. Deep sequencing of artificial mirtrons suggests that functional mature transcripts corresponding to the designed sequence were produced in high abundance. They were further shown to be splicing-dependent, Drosha-independent, and partially dependent on exportin-5, resulting in the precise generation of pre-miRNAs. In a murine myoblast line containing a pathogenic copy of human DMPK with more than 500 CUG repeats, the DMPK artificial mirtron corrected DM1-associated splicing abnormalities of the Serca-1 mRNA, demonstrating the therapeutic potential of mirtron-mediated RNAi. Thus, further development and exploitation of the unique properties of mirtrons will benefit future research and therapeutic RNAi applications as an alternative to conventional RNAi strategies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22647847      PMCID: PMC3383964          DOI: 10.1261/rna.030601.111

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  49 in total

1.  Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo.

Authors:  Ryan L Boudreau; Inês Martins; Beverly L Davidson
Journal:  Mol Ther       Date:  2008-11-11       Impact factor: 11.454

2.  Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy.

Authors:  Susan A M Mulders; Walther J A A van den Broek; Thurman M Wheeler; Huib J E Croes; Petra van Kuik-Romeijn; Sjef J de Kimpe; Denis Furling; Gerard J Platenburg; Geneviève Gourdon; Charles A Thornton; Bé Wieringa; Derick G Wansink
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

3.  MicroRNA biogenesis via splicing and exosome-mediated trimming in Drosophila.

Authors:  Alex S Flynt; Jaclyn C Greimann; Wei-Jen Chung; Christopher D Lima; Eric C Lai
Journal:  Mol Cell       Date:  2010-06-25       Impact factor: 17.970

4.  Disturbance of the microRNA pathway by commonly used lentiviral shRNA libraries limits the application for screening host factors involved in hepatitis C virus infection.

Authors:  Qiuwei Pan; Petra E de Ruiter; Karin J von Eije; Ron Smits; Jaap Kwekkeboom; Hugo W Tilanus; Ben Berkhout; Harry L A Janssen; Luc J W van der Laan
Journal:  FEBS Lett       Date:  2011-03-02       Impact factor: 4.124

5.  A high-resolution structure of the pre-microRNA nuclear export machinery.

Authors:  Chimari Okada; Eiki Yamashita; Soo Jae Lee; Satoshi Shibata; Jun Katahira; Atsushi Nakagawa; Yoshihiro Yoneda; Tomitake Tsukihara
Journal:  Science       Date:  2009-11-27       Impact factor: 47.728

6.  Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA.

Authors:  Thurman M Wheeler; Krzysztof Sobczak; John D Lueck; Robert J Osborne; Xiaoyan Lin; Robert T Dirksen; Charles A Thornton
Journal:  Science       Date:  2009-07-17       Impact factor: 47.728

7.  Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo.

Authors:  Abdullah Ely; Tanusha Naidoo; Steven Mufamadi; Carol Crowther; Patrick Arbuthnot
Journal:  Mol Ther       Date:  2008-04-22       Impact factor: 11.454

Review 8.  Novel RNA-based strategies for therapeutic gene silencing.

Authors:  Christopher R Sibley; Yiqi Seow; Matthew J A Wood
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

9.  Alternative processing of primary microRNA transcripts by Drosha generates 5' end variation of mature microRNA.

Authors:  Haoquan Wu; Chunting Ye; Danielle Ramirez; N Manjunath
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

10.  Primary microRNA transcripts are processed co-transcriptionally.

Authors:  Mariangela Morlando; Monica Ballarino; Natalia Gromak; Francesca Pagano; Irene Bozzoni; Nick J Proudfoot
Journal:  Nat Struct Mol Biol       Date:  2008-09       Impact factor: 15.369

View more
  10 in total

Review 1.  Guidelines for the optimal design of miRNA-based shRNAs.

Authors:  Xavier Bofill-De Ros; Shuo Gu
Journal:  Methods       Date:  2016-04-12       Impact factor: 3.608

2.  Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa.

Authors:  Harry O Orlans; Michelle E McClements; Alun R Barnard; Cristina Martinez-Fernandez de la Camara; Robert E MacLaren
Journal:  Nat Commun       Date:  2021-08-16       Impact factor: 14.919

3.  Functional VEGFA knockdown with artificial 3'-tailed mirtrons defined by 5' splice site and branch point.

Authors:  Kian Hong Kock; Kiat Whye Kong; Shawn Hoon; Yiqi Seow
Journal:  Nucleic Acids Res       Date:  2015-06-18       Impact factor: 16.971

4.  Splicing-dependent expression of microRNAs of mirtron origin in human digestive and excretory system cancer cells.

Authors:  Stasė Butkytė; Laurynas Čiupas; Eglė Jakubauskienė; Laurynas Vilys; Paulius Mocevicius; Arvydas Kanopka; Giedrius Vilkaitis
Journal:  Clin Epigenetics       Date:  2016-03-25       Impact factor: 6.551

5.  TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.

Authors:  Ching-Chieh Chou; Yi Zhang; Mfon E Umoh; Spencer W Vaughan; Ileana Lorenzini; Feilin Liu; Melissa Sayegh; Paul G Donlin-Asp; Yu Han Chen; Duc M Duong; Nicholas T Seyfried; Maureen A Powers; Thomas Kukar; Chadwick M Hales; Marla Gearing; Nigel J Cairns; Kevin B Boylan; Dennis W Dickson; Rosa Rademakers; Yong-Jie Zhang; Leonard Petrucelli; Rita Sattler; Daniela C Zarnescu; Jonathan D Glass; Wilfried Rossoll
Journal:  Nat Neurosci       Date:  2018-01-08       Impact factor: 24.884

6.  Identification and Characterization of an eIF4e DNA Aptamer That Inhibits Proliferation With High Throughput Sequencing.

Authors:  Wei Mei Guo; Kiat Whye Kong; Christopher John Brown; Soo Tng Quah; Hui Ling Yeo; Shawn Hoon; Yiqi Seow
Journal:  Mol Ther Nucleic Acids       Date:  2014-12-16       Impact factor: 10.183

7.  Knockdown and replacement therapy mediated by artificial mirtrons in spinocerebellar ataxia 7.

Authors:  Helen J Curtis; Yiqi Seow; Matthew J A Wood; Miguel A Varela
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

Review 8.  MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy.

Authors:  Arturo López Castel; Sarah Joann Overby; Rubén Artero
Journal:  Int J Mol Sci       Date:  2019-11-09       Impact factor: 5.923

Review 9.  Skeletal muscle in health and disease.

Authors:  Jennifer Morgan; Terence Partridge
Journal:  Dis Model Mech       Date:  2020-02-06       Impact factor: 5.758

10.  Posttranscriptional Regulation of the Human ABCG2 Multidrug Transporter Protein by Artificial Mirtrons.

Authors:  Anita Schamberger; György Várady; Ábel Fóthi; Tamás I Orbán
Journal:  Genes (Basel)       Date:  2021-07-13       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.